These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37637689)

  • 1. Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma.
    Wang J; Luo LZ; Liang DM; Guo C; Huang ZH; Jian XH; Wen J
    World J Clin Cases; 2023 Aug; 11(23):5416-5429. PubMed ID: 37637689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial stress and mitokines in aging.
    Burtscher J; Soltany A; Visavadiya NP; Burtscher M; Millet GP; Khoramipour K; Khamoui AV
    Aging Cell; 2023 Feb; 22(2):e13770. PubMed ID: 36642986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases.
    Zhang B; Chang JY; Lee MH; Ju SH; Yi HS; Shong M
    Diabetes Metab J; 2024 Jan; 48(1):1-18. PubMed ID: 38173375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma.
    Lee HY; Nga HT; Tian J; Yi HS
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Mitokines in Diabetic Nephropathy.
    Yang M; Chen W; He L; Wang X; Liu D; Xiao L; Sun L
    Curr Med Chem; 2023 Oct; ():. PubMed ID: 37921178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review.
    Li Y; Li H; He Q; Yang X
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bibliometric study of immunotherapy for hepatocellular carcinoma.
    Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
    Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
    Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2021; 11():587479. PubMed ID: 33868990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications.
    Du YN; Zhao JW
    J Hepatocell Carcinoma; 2024; 11():1171-1183. PubMed ID: 38911292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma.
    Guerra P; Martini A; Pontisso P; Angeli P
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression.
    Kotsari M; Dimopoulou V; Koskinas J; Armakolas A
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma.
    Li T; Jiao J; Ke H; Ouyang W; Wang L; Pan J; Li X
    Front Immunol; 2023; 14():1200201. PubMed ID: 37457718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.
    Wang M; Yang X; Meng Y; Jin Z; Cao J; Xiong L; Xiong Z
    Int Immunopharmacol; 2023 Feb; 115():109660. PubMed ID: 36623412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
    Papadakos SP; Arvanitakis K; Stergiou IE; Lekakis V; Davakis S; Christodoulou MI; Germanidis G; Theocharis S
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria, immunosenescence and inflammaging: a role for mitokines?
    Conte M; Martucci M; Chiariello A; Franceschi C; Salvioli S
    Semin Immunopathol; 2020 Oct; 42(5):607-617. PubMed ID: 32757036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-tissue communication of mitochondrial stress and metabolic health.
    Zhang H; Li X; Fan W; Pandovski S; Tian Y; Dillin A
    Life Metab; 2023 Feb; 2(1):. PubMed ID: 37538245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
    Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
    J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy.
    Li Q; Han J; Yang Y; Chen Y
    Front Immunol; 2022; 13():1070961. PubMed ID: 36601120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.